当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Metabolic disease: PGC1α inhibition ameliorates diabetes
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-05-31 , DOI: 10.1038/nrd.2017.97
Sarah Crunkhorn

Peroxisome proliferator-activated receptor-γ co-activator 1α (PGC1α) plays a pivotal part in energy homeostasis and is involved in the regulation of gluconeogenesis. Using a cell-based high-throughput chemical screen, Sharabi et al. have identified a small molecule, SR-18292, that increases acetylation of PGC1α, which results in

中文翻译:

代谢性疾病:抑制PGC1α可改善糖尿病

过氧化物酶体增殖物激活受体-γ共激活物1α(PGC1α)在能量稳态中起关键作用,并参与糖异生的调节。Sharabi等人使用基于细胞的高通量化学筛选。已经鉴定出一个小分子SR-18292,它可以增加PGC1α的乙酰化程度,从而导致
更新日期:2017-05-31
down
wechat
bug